Skip to main content

Articles

Original Research, Sleep, Practice Management
Changes in Medical Services and Drug Utilization and Associated Costs After Narcolepsy Diagnosis in the United States
Kathleen F. Villa, MS; Nancy L. Reaven, MA; Susan E. Funk, MBA; Karen McGaughey, PhD; Jed Black, MD
Stakeholder Perspective
Accurate Diagnosis of Chronic Diseases Can Reduce Costs and Medical Resource Utilization
James T. Kenney, RPh, MBA
Read More
Original Research
Delayed Treatment Acceleration in Patients with Rheumatoid Arthritis Who Have Inadequate Response to Initial Tumor Necrosis Factor Inhibitors: Data from the Corrona Registry
Dimitrios A. Pappas, MD; Robert A. Gerber, PharmD; Heather J. Litman, PhD; David Gruben, PhD; Jamie Geier, PhD; Winnie D. Hua, MS; Connie Chen, PharmD; Youfu Li, MD, MPH; Joel M. Kremer, MD; John S. Andrews, MD; Jeffrey A. Bourret, PharmD
Stakeholder Perspective
Limited Guidelines and Treatment Success in the Current Standard of Care for Patients with Rheumatoid Arthritis Provide an Opportunity to Inform New Treatment Protocols
Gary Branning, MBA
Read More
Perspectives
Is Adequate Nutrition Cost-Effective?
David B. Nash, MD, MBA
Read More
Original Research
Comparing Treatment Modalities for End-Stage Renal Disease: A Meta-Analysis
Gilbert L. Queeley, PhD, and Ellen S. Campbell, PhD
Stakeholder Perspective
Dialysis Procedures and Health-Related Quality of Life: The Challenge of Creating Evidence-Based Healthcare in End-Stage Renal Disease
Michael F. Murphy, MD, PhD
Read More
Practice Management
New Rivals: Integrating Health Benefits to Provide Comprehensive Patient Care
Gary Branning, MBA, and Martha Vater
Read More
Original Research, Practice Management
Effects of Educational Messaging on Urgent and Emergent Care–Seeking Behaviors Among Publicly Insured Populations
Jesse Cambon, MEng; Tristan Cordier, MS; Elizabeth L. Munnich, PhD, MPP; Andrew Renda, MD; Bobby Kapur, MD, MPH; Shkelzen Hoxhaj, MD, MPH, MBA; Meredith Williams, MD, MBA
Stakeholder Perspective
Opportunities to Improve Urgent and Emergent Care Utilization
Cody Olsen, PharmD, BCPS
Read More
Original Research, Rosacea, Dermatology
Patient Preferences and Therapeutic Satisfaction with Topical Agents for Rosacea: A Survey-Based Study
Todd Williamson, PhD, MSc; Wendy Y. Cheng, MPhil, MPH; Nora McCormick, MSc; Francis Vekeman, MA
Stakeholder Perspective
There’s Room for Improvement in Rosacea Treatment
Gary M. Owens, MD
Read More
Perspectives
20% by 2020
David B. Nash, MD, MBA
Read More
Review Article, Practice Management
Standardized Review and Approval Process for High-Cost Medication Use Promotes Value-Based Care in a Large Academic Medical System
Raghu Durvasula, MD, MHA; Janet Kelly, PharmD; Anneliese Schleyer, MD, MHA; Bradley D. Anawalt, MD; Shabir Somani, MS, MBA, RPh, FASHP; Timothy H. Dellit, MD
Stakeholder Perspective
Pharmacy & Therapeutics Committees’ New Challenge: Stewardship for Specialty Drugs
Byron C. Scott, MD, MBA
Read More
FDA Approvals, Payers' Guide
Welcome to the Ninth Annual Payers’ Guide to New FDA Approvals
Read More
Page 71 of 244
Results 701 - 710 of 2434